AARC and PALISI Clinical Practice Guideline: Pediatric Critical Asthma
Respiratory Care · 2025-05 · 70 (5) · 593-609
DOI: 10.1089/respcare.12897 ↗Kurz gefasst
Leitlinie in der Zeitschrift Respiratory Care, online erschienen am 05.05.2025. Verfasst von Benjamin R White und 22 weiteren Autor:innen. Beteiligte Einrichtung: Dr. White is affiliated with Division of Pediatric Critical Care Medicine, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Asthma, Anti-Asthmatic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 132 Literaturangaben.
Abstract (Originalsprache)
To address the lack of guidance for clinicians in their care of children with critical asthma, a multidisciplinary team of medical providers used Grading of Recommendations, Assessment, Development, and Evaluation methodology to make the following recommendations: 1. We suggest the use of continuous inhaled short-acting β agonist (SABA) over frequent intermittent SABA in children treated for critical asthma. (Conditional recommendation, very low certainty of evidence) 2. We suggest the use of either high- or low-dose continuous inhaled SABA regimens in children treated for critical asthma. (Conditional recommendation, very low certainty of evidence) 3. We suggest the use of either dexamethasone or methylprednisolone (or an equivalent dose of prednisone/prednisolone) for children treated for critical asthma. (Conditional recommendation, very low certainty of evidence) 4. We suggest the use of intravenous (IV) magnesium (intermittent or continuous) as an adjunct therapy in children treated for critical asthma. (Conditional recommendation, low certainty of evidence) 5. We cannot recommend for or against the use of IV methylxanthines as an adjunct therapy in children treated for critical asthma. (Conditional recommendation, very low certainty of evidence) 6. We suggest the use of an IV SABA infusion as an adjunct therapy in children treated for critical asthma. (Conditional recommendation, low certainty of evidence) 7. We cannot recommend for or against the application of high-flow nasal cannula versus conventional oxygen therapy in children presenting with critical asthma with persistent hypoxemia and/or respiratory distress. (Conditional recommendation, very low certainty of evidence) 8. We suggest the use of bi-level positive airway pressure over conventional oxygen therapy in children presenting with critical asthma with persistent hypoxemia and/or respiratory distress. (Conditional recommendation, very low certainty of evidence) 9. We cannot recommend for or against the application of bi-level positive airway pressure over high-flow nasal cannula for children hospitalized with critical asthma with persistent hypoxemia and/or respiratory distress. (Conditional recommendation, very low certainty of evidence) 10. We cannot recommend for or against the application of heliox in children treated for critical asthma. (Conditional recommendation, very low certainty of evidence) 11. We suggest the use of a dedicated protocol or pathway for managing children treated for critical asthma. (Conditional recommendation, low certainty of evidence)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. White is affiliated with Division of Pediatric Critical Care Medicine, University of Utah, Salt Lake City, Utah, USA.
- Mr. Miller and Dr. Rehder are affiliated with Division of Pediatric Critical Care Medicine, Duke University Medical Center, Durham, North Carolina, USA.
- Mr. Miller is affiliated with Respiratory Care Services, Duke University Medical Center, Durham, North Carolina, USA.
- Mr. Miller is affiliated with Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Mrs. Baker is affiliated with Breathing Institute, Children's Hospital Colorado Aurora, Colorado, USA.
- Dr. Basnet is affiliated with Division of Pediatric Critical Care Medicine, Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
ORCID-Profile: Hannah Craven, Abdallah Dalabih
Zitieren
APA
White, B. R., Miller, A. G., Baker, J., Basnet, S., Carroll, C. L., Craven, H., Dalabih, A., Fitzpatrick, A. M., Glogowski, J., Irazuzta, J. E., Kapuscinski, C. A., Lenox, J., Lovinsky-Desir, S., Maue, D. K., Moody, G., Newth, C., Rehder, K. J., Sochet, A. A., Said, S. J., …, & Abu-Sultaneh, S. (2025). AARC and PALISI Clinical Practice Guideline: Pediatric Critical Asthma. Respiratory Care, 70(5), 593-609. https://doi.org/10.1089/respcare.12897
Vancouver
White BR, Miller AG, Baker J, Basnet S, Carroll CL, Craven H, et al. AARC and PALISI Clinical Practice Guideline: Pediatric Critical Asthma. Respiratory Care. 2025;70(5):593-609. doi:10.1089/respcare.12897
BibTeX
@article{White2025,
author = {White, Benjamin R and Miller, Andrew G and Baker, Joyce and Basnet, Sangita and Carroll, Christopher L and Craven, Hannah and Dalabih, Abdallah and Fitzpatrick, Anne M and Glogowski, Joel and Irazuzta, Jose Enrique and Kapuscinski, Christine A and Lenox, Jesslyn and Lovinsky-Desir, Stephanie and Maue, Danielle K and Moody, Gerald and Newth, Christopher and Rehder, Kyle J and Sochet, Anthony A and Said, Sana J and Willis, L Denise and Whipple, Elizabeth C and Goodfellow, Lynda and Abu-Sultaneh, Samer},
title = {AARC and PALISI Clinical Practice Guideline: Pediatric Critical Asthma},
journal = {Respiratory Care},
year = {2025},
volume = {70},
number = {5},
pages = {593--609},
doi = {10.1089/respcare.12897}
}
EUVIMED